Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   Paul O'Brien   and   Besim Ogretmen.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.093
         
        
        
     
 
    
        
        - 
            Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C18-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. 2011 Sep 15; 17(18):6097-105.
            
            
                Score: 0.093
             
 
                                        
                                
                             
                         
                        
                            
                                
                                    
                                                   Connection Strength      
 The connection strength for concepts is the sum of the scores for each matching publication.    
         Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.